Manufacturers Reduce MRP On 3 Anticancer Drugs After BCD, GST Cuts: Centre
New Delhi: Manufacturers have started to reduce the maximum retail price (MRP) on three anticancer drugs — Trastuzumab Deruxtecan, Osimertinib, and Durvalumab drugs — as directed by the government to pass on the benefits to the consumers, the Parliament was informed on Friday. The government had issued notifications to reduce basic customs duty (BCD) to […]